Title: Blood Lipid Profiles Associated with Metastatic Sites in Advanced Gastric Cancer
Version: 9 Date: 06 Oct 2024
Reviewer's report:
Dear Authors,
Thank you for effectively addressing the comments. However, the narrative text under the title
"Correlation between Serum Lipids and Metastatic Sites in Gastric Cancer" should describe the
findings of the new Table 3. The text still describes the old Table 3, which was transferred to the
supplementary material. The narrative for the new Table 3 should include the mean differences,
along with their 95% CI and p-values, for the significant associations using a pattern like this:
"Patients with peritoneal metastasis had significantly lower levels of total cholesterol (MD = ...,
95% CI: ... to ..., p = 0.001), compared to those without peritoneal metastasis, while controlling
for other metastasis sites.
Title: Blood Lipid Profiles Associated with Metastatic Sites in Advanced Gastric Cancer
Version: 9 Date: 06 Oct 2024
Reviewer's report:
Dear Authors,
Thank you for effectively addressing the comments. However, the narrative text under the title
"Correlation between Serum Lipids and Metastatic Sites in Gastric Cancer" should describe the
findings of the new Table 3. The text still describes the old Table 3, which was transferred to the
supplementary material. The narrative for the new Table 3 should include the mean differences,
along with their 95% CI and p-values, for the significant associations using a pattern like this:
"Patients with peritoneal metastasis had significantly lower levels of total cholesterol (MD = ...,
95% CI: ... to ..., p = 0.001), compared to those without peritoneal metastasis, while controlling
for other metastasis sites.
Please review this paper.
user
Title: Blood Lipid Profiles Associated with Metastatic Sites in Advanced Gastric Cancer
Version: 9 Date: 06 Oct 2024
Reviewer's report:
Dear Authors,
Thank you for effectively addressing the comments. However, the narrative text under the title
"Correlation between Serum Lipids and Metastatic Sites in Gastric Cancer" should describe the
findings of the new Table 3. The text still describes the old Table 3, which was transferred to the
supplementary material. The narrative for the new Table 3 should include the mean differences,
along with their 95% CI and p-values, for the significant associations using a pattern like this:
"Patients with peritoneal metastasis had significantly lower levels of total cholesterol (MD = ...,
95% CI: ... to ..., p = 0.001), compared to those without peritoneal metastasis, while controlling
for other metastasis sites.
assistant